Biomarin Pharmaceutical Inc (BMRN)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	2,265,080	1,859,340	1,585,000	1,362,230	1,298,860
Revenue	US$ in thousands	2,845,320	2,374,190	2,068,670	1,832,750	1,823,140
Gross profit margin		79.61%	78.31%	76.62%	74.33%	71.24%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $2,265,080K ÷ $2,845,320K
= 79.61%

The gross profit margin of Biomarin Pharmaceutical Inc has shown a consistent and positive trend over the years, indicating an improvement in its profitability. From December 31, 2020, to December 31, 2024, the gross profit margin has increased from 71.24% to 79.61%. This upward trajectory suggests that the company has been effectively managing its production costs and pricing strategies, resulting in a higher percentage of revenue retained after accounting for the cost of goods sold. A rising gross profit margin is generally viewed favorably by investors and stakeholders as it reflects the company's ability to generate profits from its core operations. Biomarin Pharmaceutical Inc's improving gross profit margin indicates operational efficiency and potential for sustained financial performance.